Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.59)
# 2,269
Out of 4,981 analysts
2
Total ratings
50%
Success rate
34.8%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $7.48
Upside: +33.69%